09/04/2026
Every year, tens of thousands of pregnant women die from the blood pressure disorder preeclampsia, while many more have babies who are stillborn or die young after failing to grow properly in the womb.
Now researchers say they have a way to make these conditions easier to predict, potentially helping problem pregnancies get treatment sooner.
Scientists who analyzed blood samples from thousands of pregnant women found that low levels of a protein called ISM2 during the first trimester were associated with higher risk of both preeclampsia and fetal growth restriction later on.
Followup lab studies of placental cells showed that ISM2 likely plays a causal role in the disorders, meaning the findings could help in the development of treatments, too.
Learn more: https://scim.ag/4i6dLvY